Cornerstone Advisors (Washington)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,801	Closed	-$13K	–	824
2020 Q1	$13K	Hold	1,801	–	–	﹤0.01%	392
2019 Q4	$43K	Hold	1,801	–	–	0.01%	256
2019 Q3	$48K	Buy	1,801 +463	+35%	+$13K	0.01%	225
2019 Q2	$36K	Hold	1,338	–	–	﹤0.01%	493
2019 Q1	$46K	Buy	+1,338	New	+$38.6K	﹤0.01%	394
2014 Q4	–	Sell	-3,290	Closed	-$83K	–	788
2014 Q3	$83K	Hold	3,290	–	–	0.07%	63
2014 Q2	$96K	Buy	+3,290	New	+$79.6K	0.09%	64

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Cornerstone Advisors (Washington)'s PTLA Position: Q2 2020 in Review

Cornerstone Advisors (Washington) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 1,801 shares — an estimated $13K sold.

Cornerstone Advisors (Washington) first reported a position in PTLA in Q2 2014 and held it in 7 quarters. The position peaked at $96K in Q2 2014. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Cornerstone Advisors (Washington) reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Cornerstone Advisors (Washington) sold 1,801 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $13K.
Cornerstone Advisors (Washington) first reported a position in Portola Pharmaceuticals, Inc. in Q2 2014 and held it in 7 quarters.
Cornerstone Advisors (Washington)'s Portola Pharmaceuticals, Inc. position peaked at $96K in Q2 2014.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q2 2020, filed 29 Jul 2020.